ACA vs EXAS · P/E 57, rev $2.88B vs rev $2.76B
Arcosa Inc (ACA) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ACA and EXAS stock pages for the full models.
Not investment advice.